Brian Gazzard

34.3k total citations · 5 hit papers
494 papers, 21.8k citations indexed

About

Brian Gazzard is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Brian Gazzard has authored 494 papers receiving a total of 21.8k indexed citations (citations by other indexed papers that have themselves been cited), including 274 papers in Infectious Diseases, 196 papers in Virology and 177 papers in Epidemiology. Recurrent topics in Brian Gazzard's work include HIV Research and Treatment (195 papers), HIV/AIDS drug development and treatment (188 papers) and HIV/AIDS Research and Interventions (138 papers). Brian Gazzard is often cited by papers focused on HIV Research and Treatment (195 papers), HIV/AIDS drug development and treatment (188 papers) and HIV/AIDS Research and Interventions (138 papers). Brian Gazzard collaborates with scholars based in United Kingdom, United States and France. Brian Gazzard's co-authors include Mark Nelson, Sundhiya Mandalia, Mark Bower, Graeme Moyle, Justin Stebbing, Frances Gotch, Anton Pozniak, Michael S. Saag, John Walsh and Robert T. Schooley and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Brian Gazzard

487 papers receiving 20.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiretroviral Therapy in Adults

2000 874 citations Brian Gazzard et al. profile →
Treatment for Adult HIV Infection

2006 767 citations Brian Gazzard et al. profile →
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV

2006 703 citations Brian Gazzard et al. profile →
Treatment for Adult HIV Infection

2004 601 citations Brian Gazzard et al. profile →
Antiretroviral Treatment for Adult HIV Infection in 2002

2002 573 citations Brian Gazzard et al. profile →

Peers

Countries citing papers authored by Brian Gazzard

Since Specialization

Citations

This map shows the geographic impact of Brian Gazzard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Gazzard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Gazzard more than expected).

Fields of papers citing papers by Brian Gazzard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Gazzard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Gazzard. The network helps show where Brian Gazzard may publish in the future.

Co-authorship network of co-authors of Brian Gazzard

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Gazzard. A scholar is included among the top collaborators of Brian Gazzard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Gazzard. Brian Gazzard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of First-Line Use of Nucleoside Analogues, Efavirenz, and Ritonavir-Boosted Protease Inhibitors on Lipid Levels 2009 ·HIV Clinical Trials ·Andrew Hill, Will Sawyer, Brian Gazzard	42
2	Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection 2008 ·Journal of Clinical Oncology ·Thomas Powles, David Robinson, Justin Stebbing, Jonathan Shamash, Mark Nelson, Brian Gazzard, (unknown), Henrik Møller, Mark Bower	269
3	Commentary: resistance testing--a clinical perspective. 1999 ·Sexually Transmitted Infections ·Brian Gazzard, Graeme Moyle	1
4	Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea 1999 ·Gut ·D Sharpstone, Penny Neild, R Crane, Chris Taylor, Carol Hodgson, Roy Sherwood, Brian Gazzard, Ingvar Bjarnason	107
5	Ritonavir 1996 ·Drugs ·Brian Gazzard	1
6	Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. 1995 ·Gut ·J. J. Keating, Ingvar Bjarnason, Siva G. Somasundaram, Andrew J. Macpherson, N. Francis, (unknown), D Sharpstone, (unknown), I. S. Menzies, Brian Gazzard	113
7	Natural history and prognosis of diarrhoea of unknown cause in patients with acquired immunodeficiency syndrome (AIDS). 1995 ·Gut ·C Blanshard, Brian Gazzard	37
8	Cytotoxic and humoral immune responses to HIV-1 p17 synthetic peptide HGP-30 in human volunteers 1994 ·Prem S. Sarin, (unknown), Paul H. Naylor, Jeffrey Kahn, Peter N.R. Heseltine, Brian Gazzard, M Youle, (unknown), Allan L. Goldstein	1
9	Characterization of HIV-1 Strains Isolated from Patients Treated with TIBO R82913 1994 ·AIDS Research and Human Retroviruses ·Anne–Mieke Vandamme, Zeger Debyser, Rudi Pauwels, K De Vreese, Patrick Goubau, Mike Youle, Brian Gazzard, Paul Stoffels, G. Cauwenbergh, Jozef Anné, Koen Andries, Paul A. J. Janssen, Jan Desmyter, Erik De Clercq	36
10	AIDS surveillance: a direct assessment of under-reporting 1993 ·AIDS ·Matthew Hickman, (unknown), Brian Gazzard, (unknown)	7
11	HIV and AIDS : your questions answered 1993 ·Churchill Livingstone eBooks ·(unknown), Simon Barton, Brian Gazzard	0
12	Simultaneous infection with two types of intestinal microsporidia in a patient with AIDS. 1992 ·Gut ·C Blanshard, (unknown), Christopher S. Peacock, D G Tovey, D. S. Ellis, Elizabeth U. Canning, Brian Gazzard	34
13	Investigation of seemingly pathogen-negative diarrhoea in patients infected with HIV1. 1990 ·Gut ·G M Connolly, Alastair Forbes, Brian Gazzard	51
14	Non-cryptosporidial diarrhoea in human immunodeficiency virus (HIV) infected patients. 1989 ·Gut ·G M Connolly, D.C. Shanson, D A Hawkins, (unknown), Brian Gazzard	65
15	Cryptosporidial diarrhoea in AIDS and its treatment. 1988 ·Gut ·G M Connolly, Matthew Dryden, D.C. Shanson, Brian Gazzard	104
16	Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. 1985 ·Gut ·M I Filipe, F Potet, Wladimir V. Bogomoletz, Paul A. Dawson, Bettina Fabiani, (unknown), (unknown), Brian Gazzard, D Goldfain, R Zeegen	159
17	AIDS and the health professions 1985 ·BMJ ·G.A.J. Ayliffe, (unknown), M.W. Casewell, J. Craske, Brian Gazzard, D.C. Shanson, (unknown), P. B. A. Kernoff, W. Brumfitt, Don Jeffries, C Keane, (unknown), (unknown), (unknown), (unknown), J.B. Selkon, D. C. E. Speller, (unknown)	3
18	Kingella kingae septicaemia with a clinical presentation resembling disseminated gonococcal infection. 1984 ·BMJ ·D.C. Shanson, Brian Gazzard	10
19	Ulcerative enteritis and liver disease in a patient with coeliac disease. 1983 ·Gut ·Peter Lance, Brian Gazzard	5
20	Mucin secretion in inflammatory bowel disease: correlation with disease activity and dysplasia. 1982 ·Gut ·(unknown), M I Filipe, Brian Gazzard	93

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact